When it comes to science, deep technology, and the advancement of human civilization — China has ambitions not just to compete, but to lead. Don’t miss a beat in China’s steady progress in all things science, health, medicine, and deep technology.
Gao Fu, the director of China’s CDC, suggested mixing vaccines, adding doses, and looking into mRNA technology to improve the efficacy of COVID-19 shots. He later insisted that he wasn’t “admitting” to a low effectiveness of Chinese vaccines.
With five approved COVID-19 vaccines, China aims to give shots to 40% of its population in the next four months, while also delivering huge amounts of doses to Indonesia, Brazil, and Mexico.
According to the UN, the world still needs to dramatically increase its climate commitments to avert disaster. China has promised that its emissions will peak by 2030 — and political meetings in Beijing may soon reveal detail on whether, and how, that is likely to happen.
On the same day that U.S. regulators cleared the way for the Johnson & Johnson vaccine to become the country's third approved COVID-19 shot, two more Chinese companies applied for public rollouts of their vaccines in China.
WHO scientists had arguments in Wuhan over access to detailed patient data. But they appear to disagree about whether those debates amount to a “refusal” by China to share information essential to tracing the origin of COVID-19.
China is millions of doses behind the U.S. in its COVID-19 vaccine rollout, and officials are reportedly pushing back their timeline for the first 50 million shots. Vaccine diplomacy abroad, and vaccine hesitancy at home, are slowing China’s domestic rollout.
CoronaVac, a vaccine by Sinovac Biotech, may only be a little more than 50% effective in preventing COVID-19, according to clinical trial results in Brazil. While this clears the threshold for regulatory approval, it is a disappointing result for countries that already bought tens of millions of doses of the product.
The province surrounding Beijing is responding rapidly to a new outbreak of COVID-19, hoping to stop the spread of the virus before travel for Chinese New Year commences.
Chinese regulators gave approval for a mass public rollout of a COVID-19 vaccine by Sinopharm on December 30, 2020. Meanwhile, authorities worked to expand an emergency use authorization program that has already delivered millions of experimental vaccine doses.
The Chang’e-5 probe has landed in Inner Mongolia with a cargo of lunar rocks and soil.